Manager, Customer Analytics & Insights, EMD
Jazz Pharmaceuticals
Summary
At Jazz, we are reimagining how we design and deliver more precise customer experiences, enabled by new technologies, modern ways of working, and high-performing team behaviors. Through this work, we enable teams to better understand patients, caregivers, and HCPs, anticipate their needs across the enterprise, deliver timely and personalized engagement, and orchestrate seamless, end-to-end experiences as One Jazz.
Job description
The Manager, Customer Analytics & Insights, plays a key role in delivering data-driven insights that support franchise strategy, performance tracking, and business decisions. Reporting to the Director, Customer Analytics & Insights, this role is responsible for conducting secondary data analytics, supporting primary market research, and translating findings into clear, actionable recommendations. This individual works within a matrixed environment and across multiple customer types to balance analytical execution, insight synthesis, and collaboration to help improve customer experience outcomes.
Essential Functions/Responsibilities
Analytics & Insight Generation
- Conduct in-depth analysis of secondary data sources (e.g., claims, EHR/EMR, specialty pharmacy, Rx, CRM, media/omnichannel ecosystem)
- Synthesize insights across data sources, identifying broader trends and implications to inform brand planning, lifecycle strategy, performance optimization, and HCP/patient journeys.
- Apply advanced data analytics techniques and structured analytical approaches, including segmentation, to distinguish patterns, drivers, and opportunities.
- Develop and maintain standardized dashboards, reports, and analytical tools that enable ongoing monitoring of brand and portfolio performance.
- Support data quality and consistency efforts, including validation and alignment across data sources and reporting outputs.
Market Research & Voice of Customer
- Design and execute qualitative and quantitative primary market research to understand needs and behaviors across customer types (HCPs, HCOs, patients, medical/KOLs, payers).
- Integrate primary research and secondary data insights to provide a comprehensive view of customer perspectives and needs.
- Interpret and communicate research findings to cross-functional stakeholders, translating results into clear implications for brand strategy and execution.
- Perform and interpret strategic market, competitive, and landscape analyses.
Cross-Functional Collaboration & Continuous Improvement
- Partner with stakeholders across Commercial, Medical, and Market Access, to uncover key business questions and deliver relevant, integrated insights.
- Collaborate with data strategy and technology teams to align on data sources, methodologies, and analytical outputs.
- Support the development of standardized analytical frameworks to improve efficiency and capability.
- Identify opportunities to enhance research processes, tools, and best practices with a continuous growth mindset.
Required Knowledge, Skills, and Abilities
- Experience analyzing secondary pharmaceutical data sources, such as claims, EHR/EMR, specialty pharmacy, and/or prescriber-level data.
- Strong proficiency with primary market research methodologies, including qualitative (e.g., interviews, focus groups) and quantitative approaches (e.g., surveys, segmentation).
- Proficiency with analytics, visualization, and querying tools (e.g., Power BI, Tableau, Excel, SQL, Python, R, or SAS).
- Experience with pharma or healthcare datasets (e.g., IQVIA DDD, Xponent, patient claims data)
- Structured problem-solving skills, with the ability to break down complex business questions into practical analytical solutions.
- Track record of being a collaborative team player, self-starter, and adaptive to meeting the evolving needs of a fast-paced matrixed organization.
Required/Preferred Education and Licenses
- Bachelor’s degree in a quantitative, scientific, business, or related field required.
- 4 to 6+ years of progressive experience in analytics, market research, or consulting.
- Advanced degree (MBA or relevant graduate degree) preferred.
- Experience in healthcare, pharmaceutical, or other highly regulated industries preferred.
Requirements
- Bachelor’s degree in a quantitative, scientific, business, or related field required.
- 4 to 6+ years of progressive experience in analytics, market research, or consulting.
- Experience analyzing secondary pharmaceutical data sources, such as claims, EHR/EMR, specialty pharmacy, and/or prescriber-level data.
- Strong proficiency with primary market research methodologies, including qualitative (e.g., interviews, focus groups) and quantitative approaches (e.g., surveys, segmentation).
- Proficiency with analytics, visualization, and querying tools (e.g., Power BI, Tableau, Excel, SQL, Python, R, or SAS).
- Experience with pharma or healthcare datasets (e.g., IQVIA DDD, Xponent, patient claims data)
- Structured problem-solving skills, with the ability to break down complex business questions into practical analytical solutions.
- Track record of being a collaborative team player, self-starter, and adaptive to meeting the evolving needs of a fast-paced matrixed organization.
- Advanced degree (MBA or relevant graduate degree) preferred.
- Experience in healthcare, pharmaceutical, or other highly regulated industries preferred.
Benefits
- Medical, Dental & Vision
- 401(k) Retirement Plan
- Flexible Paid Vacation
- Annual Cash Bonus
- Incentive Compensation
- Equity Grants
Company overview
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company headquartered in Dublin, Ireland, with significant operations in the United States and Europe. Founded in 2003 in California, the company specializes in developing and commercializing innovative medicines for patients with serious diseases, with a primary focus on oncology and neuroscience. Jazz Pharmaceuticals is renowned for its flagship product Xyrem (sodium oxybate), which treats excessive daytime sleepiness and cataplexy in narcolepsy patients, generating substantial revenue for the company. The company's portfolio also includes treatments for epilepsy, sleep disorders, hematology, and oncology, with notable products such as Erwinaze, Defitelio, FazaClo, and Vyxeos. Through strategic acquisitions including GW Pharmaceuticals in 2021, Jazz expanded its neuroscience portfolio with cannabis-based medicines like Epidiolex for severe epilepsy syndromes. With approximately 2,800 employees worldwide and operations across multiple continents, Jazz Pharmaceuticals maintains a strong commitment to research and development, focusing on transforming biopharmaceutical discoveries into novel therapies for patients with limited treatment options. The company operates manufacturing facilities in Ireland, England, and Italy, and continues to pursue innovative approaches to address critical unmet medical needs in specialized therapeutic areas.